VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $155 | -11.9% | 25,990 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $176 | -8.3% | 25,990 | 0.0% | 0.01% | -17.6% |
| Q4 2022 | $192 | -99.8% | 25,990 | +138.7% | 0.02% | +70.0% |
| Q3 2022 | $108,000 | -9.2% | 10,890 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $119,000 | -3.3% | 10,890 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $123,000 | -28.1% | 10,890 | 0.0% | 0.01% | -30.8% |
| Q4 2021 | $171,000 | -8.6% | 10,890 | 0.0% | 0.01% | -13.3% |
| Q3 2021 | $187,000 | -20.1% | 10,890 | 0.0% | 0.02% | -21.1% |
| Q2 2021 | $234,000 | +42.7% | 10,890 | 0.0% | 0.02% | +26.7% |
| Q1 2021 | $164,000 | +14.7% | 10,890 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $143,000 | +36.2% | 10,890 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $105,000 | -18.0% | 10,890 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $128,000 | +13.3% | 10,890 | 0.0% | 0.02% | -6.2% |
| Q1 2020 | $113,000 | – | 10,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |